ArticleAmerican journal of translational research2025
Sirius Cutting Mode enhances vision and reduces myopia severity through personalized treatment.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo assess the reliability of vision correction for presbyopia using the Sirius Cutting Mode and its effect on visual acuity, corneal mechanics, and high-order aberrations over time.
methodsThis retrospective study analyzed data from 150 presbyopic patients. Of these, 74 received personalized vision correction using the Sirius Cutting Mode, while 76 served as controls with no presbyopia treatment. Participants were selected from a predefined database based on strict inclusion and exclusion criteria. Data on spherical equivalent, visual acuity, stereo testing, eye mechanics, and high-order aberrations were collected at baseline and at the end of the follow-up period. Multivariate regression analysis was conducted to identify factors influencing near visual acuity outcome.
resultsThe treatment group demonstrated significant improvements in uncorrected distance visual acuity (UDVA) and near visual acuity (NVA) at all follow-up intervals compared to the control group (both P < 0.001). Additionally, the treatment group showed a significant reduction in myopia, with lower spherical equivalent values at 10 days, 1 month, 3 months, and 6 months (all P < 0.001). High-order aberrations were significantly reduced, and corneal biomechanical properties, including maximum deformation amplitude and maximum deformation curvature radius, and improved at 6 months (all P < 0.001). Multivariate analysis identified the Sirius Cutting Mode as a significant predictor of NVA outcomes (P < 0.001).
conclusionThe Sirius Cutting Mode with personalized treatment results in improved vision for both near and far distances, reduced myopia severity, and decreased higher-order aberrations in presbyopic patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.